In 1919, Heidelberger and Walter A. Jacobs synthesized a variant of the aromatic arsenical Salvarsan, Paul Ehrlich's "magic bullet" for syphilis, which proved effective against trypanosomes, the parasites that cause African sleeping sickness. They called it tryparsamide. Louise Pearce conducted the successful (and to her own health, risky) human field trials of tryparsamide in the Belgian Congo, a colonial region of Africa in which the disease was endemic. In this letter she described her voyage to Africa, the conventional treatment for the disease administered in the local hospital in Leopoldville (today Kinshasa), and Pearce's efforts to enlist sick patients for the trial.
Item is handwritten.
Number of Image Pages:
2 (61,294 Bytes)
Date:
1920-07-17 (July 17, 1920)
Creator:
Pearce, Louise
Recipient:
Heidelberger, Michael
Rights:
Courtesy of Michael Heidelberger.
The National Library of Medicine's Profiles in Science
program has made every effort to secure proper permissions
for posting items on the web site. In this instance, however,
it has either not been possible to identify or contact the
current copyright owner.
If you have information regarding the copyright owner,
please contact us at
profiles@nlm.nih.gov.
Subject:
Medical Subject Headings (MeSH):
Trypanosomiasis, African
Exhibit Category:
The Making of an Immunologist: Heidelberger's Years at the Rockefeller Institute, 1912-1927
